(131)I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma

Lignende værker

• Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab
  af: Gopal, Ajay K., et al.
  Udgivet: (2008)
• (131)I-Tositumomab Myeloablative Radioimmunotherapy for Non-Hodgkin Lymphoma: Radiation Dose to Testes
  af: Hattori, Naoya, et al.
  Udgivet: (2012)
• Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
  af: Park, Steven I., et al.
  Udgivet: (2010)
• A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations
  af: Pagel, John M., et al.
  Udgivet: (2009)
• Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy
  af: Pagel, John M., et al.
  Udgivet: (2008)